166 related articles for article (PubMed ID: 38480611)
1. Identification of a novel gene signature related to prognosis and metastasis in gastric cancer.
Elizazu J; Artetxe-Zurutuza A; Otaegi-Ugartemendia M; Moncho-Amor V; Moreno-Valladares M; Matheu A; Carrasco-Garcia E
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38480611
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
Front Oncol; 2021; 11():799223. PubMed ID: 35096599
[TBL] [Abstract][Full Text] [Related]
4. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
5. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
6. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
7. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
8. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
9. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
10. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
Zhao H; Liu G; Li Y; Yang N; Zhao J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
[TBL] [Abstract][Full Text] [Related]
11. MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer.
Li T; Deng L; He X; Jiang G; Hu F; Ye S; You Y; Duanmu J; Dai H; Huang G; Tang C; Lei X
Cancer Manag Res; 2019; 11():9353-9369. PubMed ID: 31807065
[TBL] [Abstract][Full Text] [Related]
12. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
13. TREM1 promotes cancer associated malignant phenotype through activated MAPK signaling pathway and predicts poor prognosis in gastric cancer.
Chen L; Huang F; Luo X; Chen Z
Heliyon; 2024 Mar; 10(5):e26852. PubMed ID: 38449634
[TBL] [Abstract][Full Text] [Related]
14. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
16. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
Shen K; Chen B; Gao W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
[TBL] [Abstract][Full Text] [Related]
17. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
18. CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma.
Giraud J; Seeneevassen L; Rousseau B; Bouriez D; Sifré E; Giese A; Nguyen TL; Tiffon C; Lippi Y; Azzi-Martin L; Pannequin J; Ménard A; Bessède E; Staedel C; Mégraud F; Belleannée G; Lehours P; Gronnier C; Dubus P; Varon C
Gastric Cancer; 2023 Mar; 26(2):234-249. PubMed ID: 36528833
[TBL] [Abstract][Full Text] [Related]
19. Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.
Liu X; Ren J; Zhou R; Wen Z; Wen Z; Chen Z; He S; Zhang H
BMC Cancer; 2023 Nov; 23(1):1106. PubMed ID: 37957566
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.
Hu G; Sun N; Jiang J; Chen X
Cancer Cell Int; 2020; 20():433. PubMed ID: 32908454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
